• 1
    Rund D, Ben-Yehuda D. Therapy-related leukemia and myelodysplasia: evolving concepts of pathogenesis and treatment. Hematology 2004; 9: 17987.
  • 2
    Raskind WH, Steinmann L, Najfeld V. Clonal development of myeloproliferative disorders: clues to hematopoietic differentiation and multistep pathogenesis of cancer. Leukemia 1998; 12: 10816.
  • 3
    Song WJ, Sullivan MG, Legare RD, Hutchings S, Tan X, Kufrin D, Ratajczak J, Resende IC, Haworth C, Hock R, Loh M, Felix C, et al. Haploinsufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukaemia. Nat Genet 1999; 23: 16675.
  • 4
    Bollag G, Clapp DW, Shih S, Adler F, Zhang YY, Thompson P, Lange BJ, Freedman MH, McCormick F, Jacks T, Shannon K. Loss of NF1 results in activation of the ras signaling pathway and leads to aberrant growth in haematopoietic cells. Nat Genet 1996; 12: 1448.
  • 5
    Luna-Fineman S, Shannon KM, Atwater SK, Davis J, Masterson M, Ortega J, Sanders J, Steinherz P, Weinberg V, Lange BJ. Myelodysplastic and myeloproliferative disorders of childhood: a study of 167 patients. Blood 1999; 93: 45966.
  • 6
    Nisse C, Lorthois C, Dorp V, Eloy E, Haguenoer JM, Fenaux P. Exposure to occupational and environmental factors in myelodysplastic syndromes. preliminary results of a case-control study. Leukemia 1995; 9: 6939.
  • 7
    Preudhomme C, Nisse C, Hebbar M, Vanrumbeke M, Brizard A, Lai JL, Fenaux P. Glutathione S transferase theta 1 gene defects in myelodysplastic syndromes and their correlation with karyotype and exposure to potential carcinogens. Leukemia 1997; 11: 15802.
  • 8
    Perera FP. Environment and cancer: who are susceptible? Science 1997; 278: 106873.
  • 9
    Strange RC, Spiteri MA, Ramachandran S, Fryer AA. Glutathione-S-transferase family of enzymes. Mutat Res 2001 Oct 1; 482: 216.
  • 10
    Hayes JD, Flanagan JU, Jowsey IR. Glutathione transferases. Annu Rev Pharmacol Toxicol 2005; 45: 5188.
  • 11
    Hayes JD, Strange RC. Glutathione S-transferase polymorphisms and their biological consequences. Pharmacology 2000; 61: 15466.
  • 12
    Norppa H. Cytogenetic biomarkers and genetic polymorphisms. Toxicol Lett 2004; 149: 30934.
  • 13
    Ross D. Metabolic basis of benzene toxicity. Eur J Haematol Suppl 1996; 60: 1118.
  • 14
    Wang L, Groves MJ, Hepburn MD, Bowen DT. Glutathione S-transferase enzyme expression in hematopoietic cell lines implies a differential protective role for T1 and A1 isoenzymes in erythroid and for M1 in lymphoid lineages. Haematologica 2000; 85: 5739.
  • 15
    West RR, Stafford DA, White AD, Bowen DT, Padua RA. Cytogenetic abnormalities in the myelodysplastic syndromes and occupational or environmental exposure. Blood 2000; 95: 20937.
  • 16
    Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. Bmj 2003; 327: 55760.
  • 17
    Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959; 22: 71948.
  • 18
    Mantel N. Chi-square tests with one degree of freedom: extensions of the mantel-haenszel procedure. J Am Statist Assoc 1963; 58: 690700.
  • 19
    DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 17788.
  • 20
    Dahabreh IJ, Economopoulos K. Meta-analysis of rare events: an update and sensitivity analysis of cardiovascular events in randomized trials of rosiglitazone. Clin Trials 2008; 5: 11620.
  • 21
    Lau J, Ioannidis JP, Schmid CH. Quantitative synthesis in systematic reviews. Ann Intern Med 1997; 127: 8206.
  • 22
    Lau J, Schmid CH, Chalmers TC. Cumulative meta-analysis of clinical trials builds evidence for exemplary medical care. J Clin Epidemiol 1995; 48: 45, 57; discussion 59–60.
  • 23
    Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994; 50: 1088101.
  • 24
    Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. Bmj 1997; 315: 62934.
  • 25
    Altman DG, Bland JM. Interaction revisited: the difference between two estimates. Bmj 2003; 326: 219.
  • 26
    Atoyebi W, Kusec R, Fidler C, Peto TE, Boultwood J, Wainscoat JS. Glutathione S-transferase gene deletions in myelodysplasia. Lancet 1997; 349: 14501.
  • 27
    Basu T, Gale RE, Langabeer S, Linch DC. Glutathione S-transferase theta 1 (GSTT1) gene defect in myelodysplasia and acute myeloid leukaemia. Lancet 1997; 349: 1450.
  • 28
    Arruda VR, Lima CS, Grignoli CR, de Melo MB, Lorand-Metze I, Alberto FL, Saad ST, Costa FF. Increased risk for acute myeloid leukaemia in individuals with glutathione S-transferase mu 1 (GSTM1) and theta 1 (GSTT1) gene defects. Eur J Haematol 2001; 66: 3838.
  • 29
    Varkonyi J, Szakaly D, Janoskuti L, Hosszufalusi N, Panczel P, Karadi I, Schoket B. Glutathione S-transferase enzyme polymorphisms in a hungarian myelodysplasia study population. Pathol Oncol Res 2008; 14: 42933.
  • 30
    Stavropoulou C, Sambani C, Rigana H, Georgakakos VN, Voutsinas G, Manola KN, Pantelias GE, Makropoulos V, Hellenic MDS Study Group. Low frequency of the glutathione-S-transferase T1-null genotype in patients with primary myelodysplastic syndrome and 5q deletion. Leukemia 2008; 22: 16436.
  • 31
    Sasai Y, Horiike S, Misawa S, Kaneko H, Kobayashi M, Fujii H, Kashima K, Taniwaki M. Genotype of glutathione S-transferase and other genetic configurations in myelodysplasia. Leuk Res 1999; 23: 97581.
  • 32
    Okada M, Okamoto T, Wada H, Takemoto Y, Kakishita E. Glutathione S-transferase theta 1 gene (GSTT1) defect in japanese patients with myelodysplastic syndromes. Int J Hematol 1997; 66: 3934.
  • 33
    Haase D, Binder C, Bunger J, Fonatsch C, Streubel B, Schnittger S, Griesinger F, Westphal G, Schoch C, Knopp A, Berkovicz D, Krieger O, et al. Increased risk for therapy-associated hematologic malignancies in patients with carcinoma of the breast and combined homozygous gene deletions of glutathione transferases M1 and T1. Leuk Res 2002; 26: 24954.
  • 34
    Chen H, Sandler DP, Taylor JA, Shore DL, Liu E, Bloomfield CD, Bell DA. Increased risk for myelodysplastic syndromes in individuals with glutathione transferase theta 1 (GSTT1) gene defect. Lancet 1996 Feb 3; 347: 2957.
  • 35
    Davies SM, Robison LL, Buckley JD, Radloff GA, Ross JA, Perentesis JP. Glutathione S-transferase polymorphisms in children with myeloid leukemia: a children's cancer group study. Cancer Epidemiol Biomarkers Prev 2000; 9: 5636.
  • 36
    Tsabouri SE, Georgiou I, Alamanos I, Bourantas KL. Increased prevalence of GSTM(1) null genotype in patients with myelodysplastic syndrome: a case-control study. Acta Haematol 2000; 104: 16973.
  • 37
    Fabiani E, D'Alo F, Scardocci A, Greco M, Di Ruscio A, Criscuolo M, Fianchi L, Pagano L, Hohaus S, Leone G, Voso MT. Polymorphisms of detoxification and DNA repair enzymes in myelodyplastic syndromes. Leuk Res 2009; 33: 106871.
  • 38
    Bull LM, White DL, Bray M, Nurgalieva Z, El-Serag HB. Phase I and II enzyme polymorphisms as risk factors for barrett's esophagus and esophageal adenocarcinoma: a systematic review and meta-analysis. Dis Esophagus 2009 Feb 13.
  • 39
    Ye Z, Song H, Higgins JP, Pharoah P, Danesh J. Five glutathione s-transferase gene variants in 23,452 cases of lung cancer and 30,397 controls: meta-analysis of 130 studies. PLoS Med 2006 Apr;3( 4): e91.
  • 40
    White DL, Li D, Nurgalieva Z, El-Serag HB. Genetic variants of glutathione S-transferase as possible risk factors for hepatocellular carcinoma: a HuGE systematic review and meta-analysis. Am J Epidemiol 2008; 167: 37789.
  • 41
    Hashibe M, Brennan P, Strange RC, Bhisey R, Cascorbi I, Lazarus P, Oude Ophuis MB, Benhamou S, Foulkes WD, Katoh T, Coutelle C, Romkes M, et al. Meta- and pooled analyses of GSTM1, GSTT1, GSTP1, and CYP1A1 genotypes and risk of head and neck cancer. Cancer Epidemiol Biomarkers Prev 2003; 12: 150917.
  • 42
    Raimondi S, Botteri E, Iodice S, Lowenfels AB, Maisonneuve P. Gene-smoking interaction on colorectal adenoma and cancer risk: review and meta-analysis. Mutat Res 2009 Jul 7.
  • 43
    Raimondi S, Paracchini V, Autrup H, Barros-Dios JM, Benhamou S, Boffetta P, Cote ML, Dialyna IA, Dolzan V, Filiberti R, Garte S, Hirvonen A, et al. Meta- and pooled analysis of GSTT1 and lung cancer: a HuGE-GSEC review. Am J Epidemiol 2006; 164: 102742.
  • 44
    Ye Z, Song H. Glutathione s-transferase polymorphisms (GSTM1, GSTP1 and GSTT1) and the risk of acute leukaemia: a systematic review and meta-analysis. Eur J Cancer 2005; 41: 9809.
  • 45
    Garte S, Gaspari L, Alexandrie AK, Ambrosone C, Autrup H, Autrup JL, Baranova H, Bathum L, Benhamou S, Boffetta P, Bouchardy C, Breskvar K, et al. Metabolic gene polymorphism frequencies in control populations. Cancer Epidemiol Biomarkers Prev 2001; 10: 123948.
  • 46
    Chen B, Zhao WL, Jin J, Xue YQ, Cheng X, Chen XT, Cui J, Chen ZM, Cao Q, Yang G, Yao Y, Xia HL, et al. Clinical and cytogenetic features of 508 chinese patients with myelodysplastic syndrome and comparison with those in western countries. Leukemia 2005; 19: 76775.
  • 47
    Matsuda A, Germing U, Jinnai I, Misumi M, Kuendgen A, Knipp S, Aivado M, Iwanaga M, Miyazaki Y, Tsushima H, Sakai M, Bessho M, et al. Difference in clinical features between japanese and german patients with refractory anemia in myelodysplastic syndromes. Blood 2005 Oct 15; 106: 263340.
  • 48
    Kuendgen A, Matsuda A, Germing U. Differences in epidemiology of MDS between western and eastern countries: ethnic differences or environmental influence? Leuk Res 2007; 31: 1034.
  • 49
    Sorahan T, Kinlen LJ, Doll R. Cancer risks in a historical UK cohort of benzene exposed workers. Occup Environ Med 2005; 62: 2316.
  • 50
    Erexson GL, Wilmer JL, Kligerman AD. Sister chromatid exchange induction in human lymphocytes exposed to benzene and its metabolites in vitro. Cancer Res 1985; 45: 24717.
  • 51
    Kim SY, Choi JK, Cho YH, Chung EJ, Paek D, Chung HW. Chromosomal aberrations in workers exposed to low levels of benzene: association with genetic polymorphisms. Pharmacogenetics 2004; 14: 45363.
  • 52
    Levay G, Ross D, Bodell WJ. Peroxidase activation of hydroquinone results in the formation of DNA adducts in HL-60 cells, mouse bone marrow macrophages and human bone marrow. Carcinogenesis 1993; 14: 232934.
  • 53
    Snyder R, Witz G, Goldstein BD. The toxicology of benzene. Environ Health Perspect 1993; 100: 293306.
  • 54
    Xu X, Wiencke JK, Niu T, Wang M, Watanabe H, Kelsey KT, Christiani DC. Benzene exposure, glutathione S-transferase theta homozygous deletion, and sister chromatid exchanges. Am J Ind Med 1998; 33: 15763.